Analysis of antigen-specific T-cell responses with synthetic peptides - What kind of peptide for which purpose?

Human Immunology

Volumn 65, Issue 5, 2004, Pages 523-536

  Kiecker, Felix ^a   Streitz, Mathias ^a   Ay, Bernhard ^a   Cherepnev, Georgy ^a   Volk, Hans Dieter ^a   Volkmer Engert, Rudolf ^a   Kern, Florian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

antigen specific T cells; cytomegalovirus; epitopes; Peptides

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; HLA A ANTIGEN; SYNTHETIC PEPTIDE; TETRAMER;

AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DONOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

AMIDES; AMINO ACID SEQUENCE; AMINO ACIDS; BREFELDIN A; CD8-POSITIVE T-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; GLYCINE; HLA-A ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 2542438553     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.02.017     Document Type: Article

References (30)

1. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 1998 Jun 19;280(5371): 1821]. Science. 274:1996;94
2. Rammensee H.G., Bachmann J., Stefanovic S. MHC ligands and binding motifs. 1997;Landes Bioscience, Georgetown, TX
3. Kern F., Surel I.P., Brock C., Freistedt B., Radtke H., Scheffold A., Blasczyk R., Reinke P., Schneider-Mergener J., Radbruch A., Walden P., Volk H.D. T-cell epitope mapping by flow cytometry. Nat Med. 4:1998;975
4. Kern F., Surel I.P., Faulhaber N., Frommel C., Schneider-Mergener J., Schonemann C., Reinke P., Volk H.D. Target structures of the CD8(+)-T-cell response to human cytomegalovirus the 72-kilodalton major immediate-early protein revisited. J Virol. 73:(10):1999;8179
5. Kern F., Faulhaber N., Frömmel C., Khatamzas E., Prösch S., Schönemann C., Kretzschmar I., Volkmer-Engert R., Volk H.-D., Reinke P. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur J Immunol. 30:2000;1676
6. Tobery T.W., Wang S., Wang X.M., Neeper M.P., Jansen K.U., McClements W.L., Caulfield M.J. A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay. J Immunol Methods. 254:2001;59
7. Sherman L.A., Burke T.A., Biggs J.A. Extracellular processing of peptide antigens that bind class I major histocompatibility molecules. J Exp Med. 175:1992;1221
8. Accapezzato D., Nisini R., Paroli M., Bruno G., Bonino F., Houghton M., Barnaba V. Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis delta antigen. J Immunol. 160:1998;5262
9. Nakagawa Y., Takeshita T., Berzofsky J.A., Takahashi H. Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes. Immunology. 101:2000;76
10. Kramer A., Reineke U., Dong L., Hoffmann B., Hoffmuller U., Winkler D., Volkmer-Engert R., Schneider-Mergener J. Spot synthesis observations and optimizations. J Pept Res. 54:1999;319
11. Fields G.B., Noble R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res. 35:1990;161
12. Hoffmeister B., Kiecker F., Tesfa L., Volk H.D., Picker L.J., Kern F. Mapping T cell epitopes by flow cytometry. Methods. 29:2003;270
13. Wills M.R., Carmichael A.J., Mynard K., Jin X., Weekes M.P., Plachter B., Sissons J.G. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65 frequency, specificity, and T- cell receptor usage of pp65-specific CTL. J Virol. 70:1996;7569
14. Diamond D.J., York J., Sun J.Y., Wright C.L., Forman S.J. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood. 90:1997;1751
15. Kostense S., Vandenberghe K., Joling J., Van Baarle D., Nanlohy N., Manting E., Miedema F. Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS. Blood. 99:2002;2505
16. Kostense S., Otto S.A., Knol G.J., Manting E.H., Nanlohy N.M., Jansen C., Lange J.M., van Oers M.H., Miedema F., van Baarle D. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells. Eur J Immunol. 32:2002;1080
17. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A., Ogg G.S., Spiegel H.M., Conlon C., Spina C.A., Havlir D.V., Richman D.D., Waters A., Easterbrook P., McMichael A.J., Rowland-Jones S.L. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 192:2000;63
18. Draenert R., Altfeld M., Brander C., Basgoz N., Corcoran C., Wurcel A.G., Stone D.R., Kalams S.A., Trocha A., Addo M.M., Goulder P.J., Walker B.D. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J Immunol Methods. 275:2003;19
19. Kern F., Bunde T., Faulhaber N., Kiecker F., Khatamzas E., Rudawski I.M., Pruss A., Gratama J.W., Volkmer-Engert R., Ewert R., Reinke P., Volk H.D., Picker L.J. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis. 185:2002;1709
20. Rodda S.J. Peptide libraries for T cell epitope screening and characterization. J Immunol Methods. 267:2002;71
21. Khattab B.A.-M., Lindenmaier W., Frank F., Link H. Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes. J Med Virol. 52:1997;68
22. Goulder P.J., Addo M.M., Altfeld M.A., Rosenberg E.S., Tang Y., Govender U., Mngqundaniso N., Annamalai K., Vogel T.U., Hammond M., Bunce M., Coovadia H.M., Walker B.D. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays. J Virol. 75:2001;1339
23. Elkington R., Walker S., Crough T., Menzies M., Tellam J., Bharadwaj M., Khanna R. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol. 77:2003;5226
24. Bitmansour A.D., Douek D.C., Maino V.C., Picker L.J. Direct ex vivo analysis of human CD4(+) memory T cell activation requirements at the single clonotype level. J Immunol. 169:2002;1207
25. Maecker H.T., Dunn H.S., Suni M.A., Khatamzas E., Pitcher C.J., Bunde T., Persaud N., Trigona W., Fu T.M., Sinclair E., Bredt B.M., McCune J.M., Maino V.C., Kern F., Picker L.J. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods. 255:2001;27
26. Maecker H.T., Ghanekar S.A., Suni M.A., He X.S., Picker L.J., Maino V.C. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens. J Immunol. 166:2001;7268
27. Fournier P., Ammerlaan W., Ziegler D., Giminez C., Rabourdin-Combe C., Fleckenstein B.T., Wiesmuller K.H., Jung G., Schneider F., Muller C.P. Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides. Int Immunol. 8:1996;1441
28. Muller C.P., Ammerlaan W., Fleckenstein B., Krauss S., Kalbacher H., Schneider F., Jung G., Wiesmuller K.H. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein. Int Immunol. 8:1996;445
29. Reineke U., Volkmer-Engert R., Schneider-Mergener J. Applications of peptide arrays prepared by the SPOT-technology. Curr Opin Biotechnol. 12:2001;59
30. Bhargava S., Licha K., Knaute T., Ebert B., Becker A., Grotzinger C., Hessenius C., Wiedenmann B., Schneider-Mergener J., Volkmer-Engert R. A complete substitutional analysis of VIP for better tumor imaging properties. J Mol Recognit. 15:2002;145